These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15969876)

  • 1. Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults.
    Howard DR; Haribhakti R; Kittner B; Agrawala P
    Curr Med Res Opin; 2005 May; 21(5):769-76. PubMed ID: 15969876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis.
    Sussman GL; Mason J; Compton D; Stewart J; Ricard N
    J Allergy Clin Immunol; 1999 Jul; 104(1):100-6. PubMed ID: 10400846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males.
    Kosoglou T; Radwanski E; Batra VK; Lim JM; Christopher D; Affrime MB
    Clin Ther; 1997; 19(5):1002-12. PubMed ID: 9385487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Once-daily immediate-release fexofenadine and sustained-release pseudoephedrine combination: a new treatment option for allergic rhinitis.
    Mansfield LE
    Expert Opin Pharmacother; 2006 May; 7(7):941-51. PubMed ID: 16634716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion.
    Horak F; Toth J; Marks B; Stübner UP; Berger UE; Jäger S; Burtin B; Duby C
    Allergy; 1998 Sep; 53(9):849-56. PubMed ID: 9788685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative bioavailability and bioequivalence of a newly developed fixed combination sachet of acetylsalicylic acid and pseudoephedrine compared with a preliminary combination.
    Lücker PW; Birkel M; Hey B; Loose I; Schaefer A
    Methods Find Exp Clin Pharmacol; 2003 Oct; 25(8):631-7. PubMed ID: 14671681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence of saxagliptin/metformin extended-release (XR) fixed-dose combination tablets and single-component saxagliptin and metformin XR tablets in healthy adult subjects.
    Boulton DW; Smith CH; Li L; Huang J; Tang A; LaCreta FP
    Clin Drug Investig; 2011; 31(9):619-30. PubMed ID: 21819160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extended-release tablets in healthy volunteers.
    Nomeir AA; Mojaverian P; Kosoglou T; Affrime MB; Nezamis J; Rodwanski E; Lin CC; Cayen MN
    J Clin Pharmacol; 1996 Oct; 36(10):923-30. PubMed ID: 8930779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
    Lee DK; Jackson CM; Soutar PC; Fardon TC; Lipworth BJ
    Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW
    Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and bioequivalence of single dose and multiple doses of immediate- and extended-release formulations of dexibuprofen in healthy Chinese subjects.
    Xu MJ; Zou C; H Chu J; Wu T; Liu SJ; Zhang J; Chen M; Liu F; Xiong NN; Ju WZ; S Tan H
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):237-46. PubMed ID: 21329626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence of oxycodone hydrochoride extended release tablets to marketed reference products OxyContin® in Canada and US.
    Gosai P; Ducharme MP; Godfrey AR; Freeman JC; Monif T; Kumar KS; Kumar S; Mudnaik R; Katikaneni P
    Int J Clin Pharmacol Ther; 2013 Nov; 51(11):895-907. PubMed ID: 23673291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioequivalence of two fexofenadine formulations in healthy human volunteers after single oral administration.
    Mendoza L; Begany P; Dyrhonova M; Emritte N; Svobodova X
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Jun; 151(1):65-7. PubMed ID: 17690742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit.
    Berkowitz RB; Woodworth GG; Lutz C; Weiler K; Weiler J; Moss M; Meeves S
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):38-45. PubMed ID: 12141718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion.
    Stübner UP; Toth J; Marks B; Berger UE; Burtin B; Horak F
    Arzneimittelforschung; 2001 Nov; 51(11):904-10. PubMed ID: 11765592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose proportionality and comparison of single and multiple dose pharmacokinetics of fexofenadine (MDL 16455) and its enantiomers in healthy male volunteers.
    Robbins DK; Castles MA; Pack DJ; Bhargava VO; Weir SJ
    Biopharm Drug Dispos; 1998 Oct; 19(7):455-63. PubMed ID: 9818712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of breviscapine and C3435T
    Zhao Y; Miao Z; Jiang M; Zhou X; Lai Y
    Xenobiotica; 2021 Mar; 51(3):366-372. PubMed ID: 33256506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged-release combination in healthy adult volunteers.
    Smith K; Hopp M; Mundin G; Leyendecker P; Bailey P; Grothe B; Uhl R; Reimer K
    Clin Ther; 2008 Nov; 30(11):2051-68. PubMed ID: 19108793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.